McKinsey & Company agrees to pay $650 million to settle federal probe over opioids work

WASHINGTON — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia on Friday.

A former McKinsey senior partner has also agreed to plead guilty to obstruction of justice for deleting documents from his laptop after he became aware of investigations into Purdue Pharma, according to the filings.Court filings say Purdue paid McKinsey more than $93 million over 15 years for a number of products, including how to improve revenue from OxyContin.

The company also tried to help Purdue get a say in shaping federal rules intended to ensure the benefits of addictive prescription drugs outweighed the risks. The government said in its new filings that that resulted in making high-dose OxyContin subject to the same oversight as lower-dose opioids and made training for prescribers voluntary rather than mandatory.

The consulting firm also agreed last year to pay health care funds and insurance companies $78 million.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Former Liberal MP's Company Suspended from Government Contracts for 90 DaysThe federal government has barred Global Health Imports, a company previously co-owned by former Liberal MP and minister Randy Boissonnault, from bidding on federal contracts. The suspension lasts for at least 90 days as the government decides on the company's status under its policies. The company has one active contract with Elections Canada, but no deliverables have been received or payments made. Reports suggest the company falsely claimed to be Indigenous-owned while applying for federal contracts.
مصدر: SooToday - 🏆 8. / 85 اقرأ أكثر »